The search for improved systemic therapy of non-small cell lung cancer--what are today's options? [electronic resource]
- Lung cancer (Amsterdam, Netherlands) Jun 2011
- 265-70 p. digital
Publication Type: Journal Article; Review
1872-8332
10.1016/j.lungcan.2011.02.020 doi
Afatinib Angiogenesis Inhibitors--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols--therapeutic use Bevacizumab Biomarkers, Pharmacological--metabolism Carcinoma, Non-Small-Cell Lung--drug therapy Cetuximab Clinical Trials as Topic Glutamates--therapeutic use Guanine--analogs & derivatives Humans Lung Neoplasms--drug therapy Pemetrexed Precision Medicine Protein-Tyrosine Kinases--antagonists & inhibitors Quinazolines--pharmacology Quinolines--pharmacology